Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric Retrospective Observation Study: Neoadjuvant Treatment and Surgery Versus Definitive Chemoradiation in the Non-Small Cell Lung Cancer (NSCLC) IIIA-N2

NCT02966769 is registered in ClinicalTrials.gov with Grupo de Investigación Clínica en Oncología Radioterapia as lead sponsor.

NCT NCT02966769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02966769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric Retrospective Observation Study: Neoadjuvant Treatment and Surgery Versus Definitive Chemoradiation in the Non-Small Cell Lung Cancer (NSCLC) IIIA-N2
Lead sponsor
Grupo de Investigación Clínica en Oncología Radioterapia
Phase
Observational
Overall status
Completed
Start date
June 30, 2016
Completion date
March 31, 2017
Enrollment
294 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemoradiation, non-small-cell lung carcinoma, stage iiia-n2, surgery, survival